Epidemiology of clinically isolated methicillin-resistant Staphylococcus aureus (MRSA) and its susceptibility to linezolid and vancomycin in Egypt: a systematic review with meta-analysis - Azzam, Ahmed; Khaled, Heba; Mosa, Maha; Refaey, Neveen; AlSaifi, Mohammed; Elsisi, Sarah; Elagezy, Fatma Khaled; Mohsen, May (BMC infectious diseases, 2023)
Keywords: Analysis; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Antibiotics; Antimicrobial agents; Bacterial Proteins - genetics; Cefoxitin; Cefoxitin - therapeutic use; Cefoxitin disc diffusion; Clinical isolates; Diffusion; Diffusion rate; Disease control; Disease susceptibility; Dosage and administration; Drug resistance; Drug resistance in microorganisms; Egypt; Egypt - epidemiology; Epidemiology; Health aspects; Hospital costs; Humans; Infectious diseases; Linezolid; Linezolid - pharmacology; Linezolid - therapeutic use; Literature reviews; MecA protein; Medical personnel; Meta-analysis; Methicillin; Methicillin-resistant Staphylococcus aureus; Methicillin-Resistant Staphylococcus aureus - genetics; Microbial Sensitivity Tests; Morbidity; Mortality; MRSA; Nosocomial infection; Oxacillin; Oxacillin disc diffusion; Penicillin; Penicillin-Binding Proteins - genetics; Prevalence; Prevalence studies (Epidemiology); Prevention; Prohibition; Public health; Risk factors; Sensitivity analysis; Staphylococcal Infections - drug therapy; Staphylococcus aureus; Staphylococcus aureus infections; Staphylococcus infections; Statistical analysis; Subgroups; Systematic review; Vancomycin; Vancomycin - pharmacology; Vancomycin - therapeutic use; Egypt; United Kingdom--UK; Linezolid; Oxacillin disc diffusion; Prevalence; Cefoxitin disc diffusion; Methicillin-resistant Staphylococcus aureus; Egypt; MRSA; Vancomycin; Epidemiology; PCR